Multiple Dose Study to Determine Safety and Tolerability of ESK-001 in Healthy Participants

NCT05431634 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

49

Enrollment

INDUSTRY

Sponsor class

Conditions

Safety and Tolerability

Interventions

DRUG: Experimental drug: ESK-001
OTHER: Placebo

Sponsor

Alumis Inc